Does the media refer more to ESTA or BLCO?

In the previous week, Establishment Labs had 2 more articles in the media than Bausch + Lomb. MarketBeat recorded 4 mentions for Establishment Labs and 2 mentions for Bausch + Lomb. Establishment Labs' average media sentiment score of 1.58 beat Bausch + Lomb's score of 0.81 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Bausch + Lomb 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer STVN or ESTA?

Establishment Labs has a consensus price target of $87.14, suggesting a potential upside of 23.27%. Given Establishment Labs' stronger consensus rating and higher possible upside, analysts plainly believe Establishment Labs is more favorable than Stevanato Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Stevanato Group 1 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.40 Establishment Labs 1 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.63

Does the media favor STVN or ESTA?

In the previous week, Establishment Labs had 3 more articles in the media than Stevanato Group. MarketBeat recorded 4 mentions for Establishment Labs and 1 mentions for Stevanato Group. Establishment Labs' average media sentiment score of 1.58 beat Stevanato Group's score of 0.00 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Stevanato Group 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Establishment Labs 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Which has stronger earnings and valuation, ESTA or LQDA?

Establishment Labs has higher revenue and earnings than Liquidia. Establishment Labs is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Establishment Labs $211.08M 9.86 -$51.06M -$1.49 N/A Liquidia $158.32M 34.71 -$68.92M $0.14 441.32

Does the media favor ESTA or LQDA?

In the previous week, Liquidia had 11 more articles in the media than Establishment Labs. MarketBeat recorded 15 mentions for Liquidia and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.58 beat Liquidia's score of 0.37 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Liquidia 6 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer LIVN or ESTA?

In the previous week, Establishment Labs had 1 more articles in the media than LivaNova. MarketBeat recorded 4 mentions for Establishment Labs and 3 mentions for LivaNova. Establishment Labs' average media sentiment score of 1.58 beat LivaNova's score of 0.58 indicating that Establishment Labs is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LivaNova 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Establishment Labs 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media favor ESTA or IRTC?

In the previous week, Establishment Labs and Establishment Labs both had 4 articles in the media. Establishment Labs' average media sentiment score of 1.58 beat iRhythm Technologies' score of 0.80 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive iRhythm Technologies 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Establishment Labs (ESTA) Competitors

$70.69 0.00 (0.00%)

Closing price 05/29/2026 04:00 PM Eastern

Extended Trading

$70.02 -0.67 (-0.95%)

As of 05:13 AM Eastern

Compare

ESTA vs. BLCO, STVN, LQDA, LIVN, and IRTC

Should you buy Establishment Labs stock or one of its competitors? MarketBeat compares Establishment Labs with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Establishment Labs include Bausch + Lomb (BLCO), Stevanato Group (STVN), Liquidia (LQDA), LivaNova (LIVN), and iRhythm Technologies (IRTC). These companies are all part of the "medical equipment" industry.

How does Establishment Labs compare to Bausch + Lomb?

Establishment Labs (NASDAQ:ESTA) and Bausch + Lomb (NYSE:BLCO) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, analyst recommendations, risk, valuation, institutional ownership, earnings and media sentiment.

Establishment Labs has higher earnings, but lower revenue than Bausch + Lomb. Establishment Labs is trading at a lower price-to-earnings ratio than Bausch + Lomb, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	9.86	-$51.06M	-$1.49	N/A
Bausch + Lomb	$5.10B	1.09	-$360M	-$0.62	N/A

Bausch + Lomb has a net margin of -4.21% compared to Establishment Labs' net margin of -19.05%. Bausch + Lomb's return on equity of 3.60% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-19.05%	-218.77%	-12.31%
Bausch + Lomb	-4.21%	3.60%	1.69%

In the previous week, Establishment Labs had 2 more articles in the media than Bausch + Lomb. MarketBeat recorded 4 mentions for Establishment Labs and 2 mentions for Bausch + Lomb. Establishment Labs' average media sentiment score of 1.58 beat Bausch + Lomb's score of 0.81 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Bausch + Lomb	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Establishment Labs currently has a consensus target price of $87.14, indicating a potential upside of 23.27%. Bausch + Lomb has a consensus target price of $18.08, indicating a potential upside of 15.46%. Given Establishment Labs' stronger consensus rating and higher possible upside, research analysts plainly believe Establishment Labs is more favorable than Bausch + Lomb.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63
Bausch + Lomb	1 Sell rating(s)	9 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.21

Establishment Labs has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market. Comparatively, Bausch + Lomb has a beta of 0.58, meaning that its stock price is 42% less volatile than the broader market.

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 11.1% of Bausch + Lomb shares are held by institutional investors. 10.0% of Establishment Labs shares are held by insiders. Comparatively, 1.5% of Bausch + Lomb shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Establishment Labs beats Bausch + Lomb on 10 of the 16 factors compared between the two stocks.

How does Establishment Labs compare to Stevanato Group?

Stevanato Group (NYSE:STVN) and Establishment Labs (NASDAQ:ESTA) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, dividends, media sentiment and valuation.

72.9% of Establishment Labs shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Stevanato Group has a beta of 0.78, meaning that its stock price is 22% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market.

Establishment Labs has a consensus price target of $87.14, suggesting a potential upside of 23.27%. Given Establishment Labs' stronger consensus rating and higher possible upside, analysts plainly believe Establishment Labs is more favorable than Stevanato Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Stevanato Group	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63

In the previous week, Establishment Labs had 3 more articles in the media than Stevanato Group. MarketBeat recorded 4 mentions for Establishment Labs and 1 mentions for Stevanato Group. Establishment Labs' average media sentiment score of 1.58 beat Stevanato Group's score of 0.00 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Stevanato Group	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Establishment Labs	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Stevanato Group has a net margin of 11.76% compared to Establishment Labs' net margin of -19.05%. Stevanato Group's return on equity of 10.27% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Stevanato Group	11.76%	10.27%	6.08%
Establishment Labs	-19.05%	-218.77%	-12.31%

Stevanato Group has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Stevanato Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Stevanato Group	€1.34B	4.22	€158.21M	€0.59	31.70
Establishment Labs	$211.08M	9.86	-$51.06M	-$1.49	N/A

Summary

Establishment Labs beats Stevanato Group on 9 of the 16 factors compared between the two stocks.

How does Establishment Labs compare to Liquidia?

Establishment Labs (NASDAQ:ESTA) and Liquidia (NASDAQ:LQDA) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability.

Establishment Labs has a beta of 1.11, indicating that its stock price is 11% more volatile than the broader market. Comparatively, Liquidia has a beta of 0.57, indicating that its stock price is 43% less volatile than the broader market.

Establishment Labs has higher revenue and earnings than Liquidia. Establishment Labs is trading at a lower price-to-earnings ratio than Liquidia, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	9.86	-$51.06M	-$1.49	N/A
Liquidia	$158.32M	34.71	-$68.92M	$0.14	441.32

In the previous week, Liquidia had 11 more articles in the media than Establishment Labs. MarketBeat recorded 15 mentions for Liquidia and 4 mentions for Establishment Labs. Establishment Labs' average media sentiment score of 1.58 beat Liquidia's score of 0.37 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Liquidia	6 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Liquidia has a net margin of 7.74% compared to Establishment Labs' net margin of -19.05%. Liquidia's return on equity of 46.82% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-19.05%	-218.77%	-12.31%
Liquidia	7.74%	46.82%	7.06%

72.9% of Establishment Labs shares are owned by institutional investors. Comparatively, 64.5% of Liquidia shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by company insiders. Comparatively, 25.6% of Liquidia shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Establishment Labs currently has a consensus target price of $87.14, indicating a potential upside of 23.27%. Liquidia has a consensus target price of $50.88, indicating a potential downside of 17.66%. Given Establishment Labs' higher possible upside, equities analysts clearly believe Establishment Labs is more favorable than Liquidia.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63
Liquidia	2 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	3 Strong Buy rating(s)	2.91

Summary

Liquidia beats Establishment Labs on 10 of the 16 factors compared between the two stocks.

How does Establishment Labs compare to LivaNova?

LivaNova (NASDAQ:LIVN) and Establishment Labs (NASDAQ:ESTA) are both mid-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, media sentiment, earnings, risk and analyst recommendations.

LivaNova has a beta of 0.88, meaning that its stock price is 12% less volatile than the broader market. Comparatively, Establishment Labs has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market.

LivaNova has a net margin of 7.48% compared to Establishment Labs' net margin of -19.05%. LivaNova's return on equity of 16.48% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
LivaNova	7.48%	16.48%	7.59%
Establishment Labs	-19.05%	-218.77%	-12.31%

97.6% of LivaNova shares are owned by institutional investors. Comparatively, 72.9% of Establishment Labs shares are owned by institutional investors. 0.4% of LivaNova shares are owned by insiders. Comparatively, 10.0% of Establishment Labs shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Establishment Labs has lower revenue, but higher earnings than LivaNova. Establishment Labs is trading at a lower price-to-earnings ratio than LivaNova, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LivaNova	$1.39B	2.92	-$242.47M	$1.95	37.85
Establishment Labs	$211.08M	9.86	-$51.06M	-$1.49	N/A

In the previous week, Establishment Labs had 1 more articles in the media than LivaNova. MarketBeat recorded 4 mentions for Establishment Labs and 3 mentions for LivaNova. Establishment Labs' average media sentiment score of 1.58 beat LivaNova's score of 0.58 indicating that Establishment Labs is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
LivaNova	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Establishment Labs	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

LivaNova presently has a consensus target price of $79.38, indicating a potential upside of 7.55%. Establishment Labs has a consensus target price of $87.14, indicating a potential upside of 23.27%. Given Establishment Labs' higher possible upside, analysts plainly believe Establishment Labs is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LivaNova	0 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.67
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63

Summary

LivaNova beats Establishment Labs on 8 of the 15 factors compared between the two stocks.

How does Establishment Labs compare to iRhythm Technologies?

Establishment Labs (NASDAQ:ESTA) and iRhythm Technologies (NASDAQ:IRTC) are both mid-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, valuation, earnings, dividends, institutional ownership, media sentiment, risk and profitability.

In the previous week, Establishment Labs and Establishment Labs both had 4 articles in the media. Establishment Labs' average media sentiment score of 1.58 beat iRhythm Technologies' score of 0.80 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
iRhythm Technologies	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Establishment Labs presently has a consensus price target of $87.14, indicating a potential upside of 23.27%. iRhythm Technologies has a consensus price target of $191.85, indicating a potential upside of 68.43%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts clearly believe iRhythm Technologies is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.63
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	11 Buy rating(s)	2 Strong Buy rating(s)	2.93

Establishment Labs has a beta of 1.11, meaning that its share price is 11% more volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.27, meaning that its share price is 27% more volatile than the broader market.

72.9% of Establishment Labs shares are owned by institutional investors. 10.0% of Establishment Labs shares are owned by insiders. Comparatively, 1.0% of iRhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

iRhythm Technologies has a net margin of -3.53% compared to Establishment Labs' net margin of -19.05%. iRhythm Technologies' return on equity of -10.26% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-19.05%	-218.77%	-12.31%
iRhythm Technologies	-3.53%	-10.26%	-1.39%

iRhythm Technologies has higher revenue and earnings than Establishment Labs. iRhythm Technologies is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	9.86	-$51.06M	-$1.49	N/A
iRhythm Technologies	$747.14M	5.01	-$44.55M	-$0.86	N/A

Summary

iRhythm Technologies beats Establishment Labs on 11 of the 16 factors compared between the two stocks.

Get Establishment Labs News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ESTA vs. The Competition

Export

Metric	Establishment Labs	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$2.08B	$8.52B	$6.40B	$12.57B
Dividend Yield	N/A	1.76%	2.68%	5.31%
P/E Ratio	-47.44	21.99	21.59	26.27
Price / Sales	9.86	19.93	551.74	114.93
Price / Cash	N/A	12.89	27.44	37.60
Price / Book	87.27	5.13	10.04	6.86
Net Income	-$51.06M	$175.77M	$3.56B	$337.26M
7 Day Performance	-2.08%	2.88%	2.83%	3.58%
1 Month Performance	N/A	N/A	N/A	-0.79%
1 Year Performance	104.07%	5.69%	37.61%	39.67%

Establishment Labs Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ESTA Establishment Labs	3.351 of 5 stars	$70.69 flat	$87.14 +23.3%	+104.1%	$2.08B	$211.08M	N/A	1,004
BLCO Bausch + Lomb	4.4539 of 5 stars	$16.15 +0.2%	$18.08 +12.0%	+36.4%	$5.76B	$5.10B	N/A	13,000
STVN Stevanato Group	2.163 of 5 stars	€17.61 -1.0%	N/A	-15.2%	€5.33B	€1.20B	29.85	6,010	Gap Down
LQDA Liquidia	2.4873 of 5 stars	$56.59 -0.7%	$49.33 -12.8%	+311.1%	$5.03B	$158.32M	404.00	50
LIVN LivaNova	2.8022 of 5 stars	$72.09 -0.2%	$77.22 +7.1%	+70.9%	$3.96B	$1.39B	36.98	3,300

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ESTA) was last updated on 6/1/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Establishment Labs (ESTA) Competitors

ESTA vs. BLCO, STVN, LQDA, LIVN, and IRTC

How does Establishment Labs compare to Bausch + Lomb?

Summary

How does Establishment Labs compare to Stevanato Group?

Summary

How does Establishment Labs compare to Liquidia?

Summary

How does Establishment Labs compare to LivaNova?

Summary

How does Establishment Labs compare to iRhythm Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ESTA vs. The Competition

Establishment Labs Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Establishment Labs (ESTA) Competitors

ESTA vs. BLCO, STVN, LQDA, LIVN, and IRTC

How does Establishment Labs compare to Bausch + Lomb?

Which has higher valuation & earnings, ESTA or BLCO?

Is ESTA or BLCO more profitable?

Does the media refer more to ESTA or BLCO?

Do analysts rate ESTA or BLCO?

Which has more risk and volatility, ESTA or BLCO?

Do institutionals and insiders believe in ESTA or BLCO?

Summary

How does Establishment Labs compare to Stevanato Group?

Do institutionals and insiders have more ownership in STVN or ESTA?

Which has more volatility and risk, STVN or ESTA?

Do analysts prefer STVN or ESTA?

Does the media favor STVN or ESTA?

Is STVN or ESTA more profitable?

Which has better valuation & earnings, STVN or ESTA?

Summary

How does Establishment Labs compare to Liquidia?

Which has more risk and volatility, ESTA or LQDA?

Which has stronger earnings and valuation, ESTA or LQDA?

Does the media favor ESTA or LQDA?

Is ESTA or LQDA more profitable?

Do insiders & institutionals hold more shares of ESTA or LQDA?

Do analysts rate ESTA or LQDA?

Summary

How does Establishment Labs compare to LivaNova?

Which has more volatility and risk, LIVN or ESTA?

Is LIVN or ESTA more profitable?

Do institutionals & insiders believe in LIVN or ESTA?

Which has preferable valuation and earnings, LIVN or ESTA?

Does the media prefer LIVN or ESTA?

Do analysts prefer LIVN or ESTA?

Summary

How does Establishment Labs compare to iRhythm Technologies?

Does the media favor ESTA or IRTC?

Do analysts recommend ESTA or IRTC?

Which has more volatility & risk, ESTA or IRTC?

Do insiders & institutionals believe in ESTA or IRTC?

Is ESTA or IRTC more profitable?

Which has preferable valuation & earnings, ESTA or IRTC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ESTA vs. The Competition

Establishment Labs Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools